Mesoblast gets FDA RMAT; List of 10 total designations so far
Australian stem cell biotech Mesoblast announced that it has received regenerative medicine advanced therapy (RMAT) designation from the U.S. FDA. This is very good news for the company and an encouraging development for the field. Interestingly, last month the FDA clarified that there is expanded RMAT designation that can include gene therapies too. At the Meeting …
Mesoblast gets FDA RMAT; List of 10 total designations so far Read More »